
    
      PRIMARY OBJECTIVES:

      I. To assess the feasibility and safety of pre-transplant single, high dose vitamin A
      supplementation in adult allogeneic stem cell transplant recipients until day +28 after
      transplant.

      OUTLINE: This is a dose-escalation study.

      Participants receive vitamin A compound orally (PO) or enterally once prior to stem cell
      transplant.

      After completion of study treatment, participants are followed up periodically.
    
  